OQROGet OQRO Pro
Insider trade

Kura Oncology (KURA)Officer sold ~$48K

Thomas James Doyle, Officer at Kura Oncology, sold ~$48K of Kura Oncology shares.

~$48K
Approx. value · 4,607 sh @ $10.50
142K
Holds after · shares reported
Traded
Sep 28, 2026
Filed
Sep 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 12, 2026Company filing · Form 8-K · ResultsReported its results
  2. Sep 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective as of September 8, 2026, the Board of Directors (the “Board”) of Kura Oncology, Inc. (the “Company”) appointed Jennifer Fulk as the Company’s Chief Financial Officer, principal financial officer (replacing Troy E. Wilson, Ph.D., J.D. solely with respect to such role) and principal accounting officer (replacing Thomas Doyle solely with respect to such role).”
  3. Sep 24, 2026InsiderOfficer sold ~$225K of KURA shares in the open market
  4. Sep 28, 2026 · this disclosureInsiderOfficer sold ~$48K of KURA shares in the open market

What came next

  1. Sep 28, 2026Insider · 4 peopleInsiders: 5 sales (~$471K)
  2. Sep 29, 2026Insider · 3 peopleInsiders: 3 sales (~$515K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kura Oncology

For Kura Oncology, OQRO holds 10 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KURA page.

Other recent filings by Thomas James Doyle, SVP, Finance & Accounting

The full history of Thomas James Doyle, SVP, Finance & Accounting is on the profile page.

How this filing works

Other disclosures at Kura Oncology

Everything OQRO holds on this company is on its KURA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data